|
|
||||||||
by NK Cells1




*
Microbiology and Tumor Biology Center, Karolinska Institute, Stockholm, Sweden;
Department of Immunology, The Scripps Research Institute, La Jolla, CA 92037;
Core Research for Evolutional Science and Technology, Japan Science and Technology Corporation, Osaka University, Osaka, Japan
IL-18 promotes NK cell and Th1 cell activity and may bridge innate
and adaptive immune responses. Myelin oligodendrocyte glycoprotein
(MOG) is a myelin component of the CNS and is a candidate autoantigen
in multiple sclerosis. In the present study we show that
IL-18-deficient (IL-18-/-) mice are defective in mounting
autoreactive Th1 and autoantibody responses and are resistant to
MOG3555 peptide-induced autoimmune encephalomyelitis.
IL-18 administration enhances the disease severity in wild-type mice
and restores the ability to generate Th1 response in the
IL-18-/- mice. This restoration was abrogated in NK
cell-depleted mice, indicating that the action of IL-18 in promoting
the generation of MOG-specific Th cells was dependent on NK cells.
Furthermore, transfer of NK cells from recombinase-activating gene
1-/- mice, but not from recombinase-activating gene
1/IFN-
-/- mice, rescued the defective Th1 responses in
IL-18-/- mice and rendered IL-18-/- mice
susceptible to the induction of autoimmune encephalomyelitis. Thus,
IL-18 can direct autoreactive T cells and promote autodestruction in
the CNS at least in part via induction of IFN-
by NK
cells.
This article has been cited by other articles:
![]() |
G. Chen, G. Han, J. Wang, R. Wang, R. Xu, B. Shen, J. Qian, and Y. Li Natural Killer Cells Modulate Overt Autoimmunity to Homeostasis in Nonobese Diabetic Mice after Anti-CD3 F(ab')2 Antibody Treatment through Secreting Transforming Growth Factor-{beta} Am. J. Pathol., September 1, 2009; 175(3): 1086 - 1094. [Abstract] [Full Text] [PDF] |
||||
![]() |
R. Winkler-Pickett, H. A. Young, J. M. Cherry, J. Diehl, J. Wine, T. Back, W. E. Bere, A. T. Mason, and J. R. Ortaldo In Vivo Regulation of Experimental Autoimmune Encephalomyelitis by NK Cells: Alteration of Primary Adaptive Responses J. Immunol., April 1, 2008; 180(7): 4495 - 4506. [Abstract] [Full Text] [PDF] |
||||
![]() |
Y-J. Lin, L. Wan, J.-C Sheu, C-M. Huang, C-W. Lin, Y-C. Lan, C-H. Lai, C-H. Hung, Y. Tsai, C-H. Tsai, et al. A/C polymorphism in the interleukin-18 coding region among Taiwanese systemic lupus erythematosus patients Lupus, February 1, 2008; 17(2): 124 - 127. [Abstract] [PDF] |
||||
![]() |
S. Nakae, Y. Iwakura, H. Suto, and S. J. Galli Phenotypic differences between Th1 and Th17 cells and negative regulation of Th1 cell differentiation by IL-17 J. Leukoc. Biol., May 1, 2007; 81(5): 1258 - 1268. [Abstract] [Full Text] [PDF] |
||||
![]() |
R. Zhou, H. Wei, and Z. Tian NK3-Like NK Cells Are Involved in Protective Effect of Polyinosinic-Polycytidylic Acid on Type 1 Diabetes in Nonobese Diabetic Mice J. Immunol., February 15, 2007; 178(4): 2141 - 2147. [Abstract] [Full Text] [PDF] |
||||
![]() |
T. Aranami, S. Miyake, and T. Yamamura Differential Expression of CD11c by Peripheral Blood NK Cells Reflects Temporal Activity of Multiple Sclerosis J. Immunol., October 15, 2006; 177(8): 5659 - 5667. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. R. Maxwell, R. Yadav, R. J. Rossi, C. E. Ruby, A. D. Weinberg, H. L. Aguila, and A. T. Vella IL-18 Bridges Innate and Adaptive Immunity through IFN-{gamma} and the CD134 Pathway J. Immunol., July 1, 2006; 177(1): 234 - 245. [Abstract] [Full Text] [PDF] |
||||
![]() |
D. Huang, F.-D. Shi, S. Jung, G. C. Pien, J. Wang, T. P. Salazar-Mather, T. T. He, J. T. Weaver, H.-G. Ljunggren, C. A. Biron, et al. The neuronal chemokine CX3CL1/fractalkine selectively recruits NK cells that modify experimental autoimmune encephalomyelitis within the central nervous system FASEB J, May 1, 2006; 20(7): 896 - 905. [Abstract] [Full Text] [PDF] |
||||
![]() |
R. Liu, L. V. Kaer, A. L. Cava, M. Price, D. I. Campagnolo, M. Collins, D. A. Young, T. L. Vollmer, and F.-D. Shi Autoreactive T Cells Mediate NK Cell Degeneration in Autoimmune Disease J. Immunol., May 1, 2006; 176(9): 5247 - 5254. [Abstract] [Full Text] [PDF] |
||||
![]() |
T. L. Vollmer, R. Liu, M. Price, S. Rhodes, A. La Cava, and F.-D. Shi Differential Effects of IL-21 during Initiation and Progression of Autoimmunity against Neuroantigen J. Immunol., March 1, 2005; 174(5): 2696 - 2701. [Abstract] [Full Text] [PDF] |
||||
![]() |
Y. Y. Setiady, P. Pramoonjago, and K. S. K. Tung Requirements of NK Cells and Proinflammatory Cytokines in T Cell-Dependent Neonatal Autoimmune Ovarian Disease Triggered by Immune Complex J. Immunol., July 15, 2004; 173(2): 1051 - 1058. [Abstract] [Full Text] [PDF] |
||||
![]() |
P. Bossu, D. Neumann, E. Del Giudice, A. Ciaramella, I. Gloaguen, G. Fantuzzi, C. A. Dinarello, E. Di Carlo, P. Musiani, P. L. Meroni, et al. IL-18 cDNA vaccination protects mice from spontaneous lupus-like autoimmune disease PNAS, November 25, 2003; 100(24): 14181 - 14186. [Abstract] [Full Text] [PDF] |
||||
![]() |
R. Deonarain, A. Verma, A. C. G. Porter, D. R. Gewert, L. C. Platanias, and E. N. Fish Critical roles for IFN-{beta} in lymphoid development, myelopoiesis, and tumor development: Links to tumor necrosis factor {alpha} PNAS, November 11, 2003; 100(23): 13453 - 13458. [Abstract] [Full Text] [PDF] |
||||
![]() |
G.-X. Zhang, S. Yu, B. Gran, J. Li, I. Siglienti, X. Chen, D. Calida, E. Ventura, M. Kamoun, and A. Rostami Role of IL-12 Receptor {beta}1 in Regulation of T Cell Response by APC in Experimental Autoimmune Encephalomyelitis J. Immunol., November 1, 2003; 171(9): 4485 - 4492. [Abstract] [Full Text] [PDF] |
||||
![]() |
C. N. Baxevanis, A. D. Gritzapis, and M. Papamichail In Vivo Antitumor Activity of NKT Cells Activated by the Combination of IL-12 and IL-18 J. Immunol., September 15, 2003; 171(6): 2953 - 2959. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. Ito, A. Matejuk, C. Hopke, H. Drought, J. Dwyer, A. Zamora, S. Subramanian, A. A. Vandenbark, and H. Offner Transfer of Severe Experimental Autoimmune Encephalomyelitis by IL-12- and IL-18-Potentiated T Cells Is Estrogen Sensitive J. Immunol., May 1, 2003; 170(9): 4802 - 4809. [Abstract] [Full Text] [PDF] |
||||
![]() |
C. Deng, C. Radu, A. Diab, M. F. Tsen, R. Hussain, J. S. Cowdery, M. K. Racke, and J. A. Thomas IL-1 Receptor-Associated Kinase 1 Regulates Susceptibility to Organ-Specific Autoimmunity J. Immunol., March 15, 2003; 170(6): 2833 - 2842. [Abstract] [Full Text] [PDF] |
||||
![]() |
G.-X. Zhang, B. Gran, S. Yu, J. Li, I. Siglienti, X. Chen, M. Kamoun, and A. Rostami Induction of Experimental Autoimmune Encephalomyelitis in IL-12 Receptor-{beta}2-Deficient Mice: IL-12 Responsiveness Is Not Required in the Pathogenesis of Inflammatory Demyelination in the Central Nervous System J. Immunol., February 15, 2003; 170(4): 2153 - 2160. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. A. Gracie, S. E. Robertson, and I. B. McInnes Interleukin-18 J. Leukoc. Biol., February 1, 2003; 73(2): 213 - 224. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. Matejuk, J. Dwyer, A. Zamora, A. A. Vandenbark, and H. Offner Evaluation of the Effects of 17{beta}-Estradiol (17{beta}-E2) on Gene Expression in Experimental Autoimmune Encephalomyelitis Using DNA Microarray Endocrinology, January 1, 2002; 143(1): 313 - 319. [Abstract] [Full Text] [PDF] |
||||
![]() |
E. Esfandiari, I. B. McInnes, G. Lindop, F.-P. Huang, M. Field, M. Komai-Koma, X.-q. Wei, and F. Y. Liew A Proinflammatory Role of IL-18 in the Development of Spontaneous Autoimmune Disease J. Immunol., November 1, 2001; 167(9): 5338 - 5347. [Abstract] [Full Text] [PDF] |
||||
![]() |
F.-D. Shi, M. Flodstrom, S. H. Kim, S. Pakala, M. Cleary, H.-G. Ljunggren, and N. Sarvetnick Control of the Autoimmune Response by Type 2 Nitric Oxide Synthase J. Immunol., September 1, 2001; 167(5): 3000 - 3006. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. Neighbors, X. Xu, F. J. Barrat, S. R. Ruuls, T. Churakova, R. Debets, J. F. Bazan, R. A. Kastelein, J. S. Abrams, and A. O'Garra A Critical Role for Interleukin 18 in Primary and Memory Effector Responses to Listeria monocytogenes That Extends Beyond Its Effects on Interferon {gamma} Production J. Exp. Med., August 6, 2001; 194(3): 343 - 354. [Abstract] [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |